Related Experiment Video

Updated: May 16, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy

François Ducray, Ahmed Idbaih

    Nature Reviews. Neurology
    |December 12, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
    07:42

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

    Published on: April 26, 2012

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:33

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    Related Experiment Videos

    Last Updated: May 16, 2026

    Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
    08:43

    Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

    Published on: November 30, 2012

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
    07:42

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

    Published on: April 26, 2012

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:33

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeted proteomics reveal histiocytosis-associated neurodegeneration signatures.

    HemaSphere·2026

    Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).

    European journal of cancer (Oxford, England : 1990)·2026

    Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Characteristics of glioma in L-2-Hydroxyglutaric Aciduria: a case report and literature review.

    Neuro-Chirurgie·2026

    Multi-omics characterization of IDH-mutant astrocytoma-derived cell lines reveals NOTCH-regulated plastic quiescent astrocyte-like state and insights into progression.

    Acta neuropathologica communications·2026

    BRAF-MEK inhibition in a giant BRAF-mutant Rathke cleft cyst: Diagnostic challenges and clinical implications for BRAF testing.

    Neuro-oncology practice·2026

    Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

    Nature reviews. Neurology·2026

    Somatic mosaicism in the brain: linking development, ageing and neurodegeneration.

    Nature reviews. Neurology·2026

    Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.

    Nature reviews. Neurology·2026

    Role of complement and complement-targeted therapeutics in neurological diseases.

    Nature reviews. Neurology·2026

    Symptomatic treatment for Alzheimer disease: current evidence and future directions.

    Nature reviews. Neurology·2026

    Effects of obesity on brain health and cognition.

    Nature reviews. Neurology·2026

    Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

    Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

    OncoTargets and therapy·2026

    Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

    Case reports in oncology·2026

    Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

    Mediastinum (Hong Kong, China)·2026

    Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

    Mediastinum (Hong Kong, China)·2026

    Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

    Mediastinum (Hong Kong, China)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us